CLOV vs VIR
Clover Health Investments Corp (CLOV) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
CLOV currently screens at market cap $1.55B. VIR currently screens at market cap $1.45B.
Not investment advice. Open the CLOV and VIR stock pages for the full models.
Not investment advice.